Sun Pharmaceutical Share Price Today | Stock Price & Sun Pharmaceutical Share Screener

Track the current stock price of Sun Pharmaceutical with an interactive chart. Analyse SUNPHARMA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sun Pharmaceutical stock quote in one place.

The quote of ₹1,760.00 sits between the 52-week low of ₹1,589.30 and the 52-week high of ₹2,001.10, and the latest session moved 0.13% from the previous close.

Screen Sun Pharmaceutical company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SUNPHARMA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with Dilip S Shanghvi listed as chairperson or CEO, and it trades under ISIN INE044A01036.

Sun Pharmaceutical Industries Limited is a global specialty generic pharmaceutical company based in India. It manufactures and markets a wide range of pharmaceutical formulations including generics, branded generics, complex products, over-the-counter drugs, and active pharmaceutical ingredients. The company has a diverse portfolio covering multiple therapeutic areas and dosage forms. Sun...more

Classification

Identifiers and Leadership

Screen SUNPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹108,785, up from ₹92,101 in 2025.

Latest statistics put total assets at ₹108,785 and shareholder funds at ₹83,880, with a leverage ratio of 0.04.

Screen Sun Pharmaceutical income statement and profit fundamentals. Analyze SUNPHARMA quarterly results. Sun Pharmaceutical reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹15,018 and net profit was ₹2,710, equal to earnings per unit of ₹11.30, at an operating margin of 27%.

In that period expenses were ₹10,658, interest cost ₹86 and tax ₹842. The next period listed, 2026-Jun, shows revenue of ₹15,907 and net profit of ₹2,901.

Screen SUNPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹12,419, and net cash flow was an outflow of ₹498.

Over the same period, investing activities used ₹10,405 and financing activities used ₹2,513.

See Sun Pharmaceutical shareholding pattern with promoter, FII, and DII holdings. Check Sun Pharmaceutical promoter holding and ownership changes for SUNPHARMA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 54.48%, foreign institutions 15.93%, domestic institutions 21.11% and the public 5.30%, spread across 690,957 shareholders.

The shareholder count was 690,957 in 2026-Mar, compared with 710,246 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sun Pharmaceutical. Sun Pharmaceutical dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹16.00 per unit for 2026-March, a yield of 0.91%, compared with ₹16.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹16.00, ₹16.00 and ₹13.50 per unit.

See which indices include Sun Pharmaceutical stock. Check SUNPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 50 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE 200 EQUAL WEIGHT, BSE INDEX BSE HC, BSE INDEX BSE100.

Get Sun Pharmaceutical corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sun Pharmaceutical stock events that may affect SUNPHARMA share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated July 31, 2026, with a record date of July 31, 2026.

It is followed by Quarterly Result Announcement dated July 31, 2026 and Dividend dated July 7, 2026.

Screen SUNPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen SUNPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 9, 2026.

The next most recent announcements are dated October 8, 2026 and October 4, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 13, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.